Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 134 Pages
Report ld: 6478786
Request Sample
Customized Report
Puerarin Market Size(US$)

CAGR 2026-2032
6.7%
Market Size,2032
USD 186
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Puerarin market was valued at US$ 119 million in 2025 and is anticipated to reach US$ 186 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Puerarin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
The industry trend for Puerarin reflects the increasing interest in natural bioactive compounds with potential therapeutic effects. With a growing demand for plant-based and holistic approaches to healthcare and wellness, there is a rising focus on botanical ingredients like Puerarin. The pharmaceutical industry is exploring the use of Puerarin in drug development, particularly for cardiovascular applications and neuroprotective effects. Additionally, the nutraceutical and dietary supplement industry is incorporating Puerarin into formulations targeting specific health concerns, including cardiovascular health, cognitive function, and menopausal symptoms. This industry trend aligns with the broader movement towards natural and plant-based alternatives in healthcare and wellness.
This report delivers a comprehensive overview of the global Puerarin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Puerarin. The Puerarin market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Puerarin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Puerarin manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Puerarin manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Puerarin production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Puerarin consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Puerarin Market Overview
1.1 Product Definition
1.2 Puerarin by Type
1.2.1 Global Puerarin Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 98% Content
1.2.3 Other Content
1.3 Puerarin by Application
1.3.1 Global Puerarin Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Pharmaceutical
1.3.3 Research
1.4 Global Market Growth Prospects
1.4.1 Global Puerarin Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Puerarin Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Puerarin Production Estimates and Forecasts (2021–2032)
1.4.4 Global Puerarin Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Puerarin Production Market Share by Manufacturers (2021–2026)
2.2 Global Puerarin Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Puerarin, Industry Ranking, 2024 vs 2025
2.4 Global Puerarin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Puerarin Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Puerarin, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Puerarin, Product Offerings and Applications
2.8 Global Key Manufacturers of Puerarin, Date of Entry into the Industry
2.9 Puerarin Market Competitive Situation and Trends
2.9.1 Puerarin Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Puerarin Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Puerarin Production by Region
3.1 Global Puerarin Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Puerarin Production Value by Region (2021–2032)
3.2.1 Global Puerarin Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Puerarin by Region (2027–2032)
3.3 Global Puerarin Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Puerarin Production Volume by Region (2021–2032)
3.4.1 Global Puerarin Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Puerarin by Region (2027–2032)
3.5 Global Puerarin Market Price Analysis by Region (2021–2032)
3.6 Global Puerarin Production, Value, and Year-over-Year Growth
3.6.1 North America Puerarin Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Puerarin Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Puerarin Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Puerarin Production Value Estimates and Forecasts (2021–2032)
4 Puerarin Consumption by Region
4.1 Global Puerarin Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Puerarin Consumption by Region (2021–2032)
4.2.1 Global Puerarin Consumption by Region (2021–2026)
4.2.2 Global Puerarin Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Puerarin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Puerarin Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Puerarin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Puerarin Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Puerarin Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Puerarin Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Puerarin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Puerarin Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Puerarin Production by Type (2021–2032)
5.1.1 Global Puerarin Production by Type (2021–2026)
5.1.2 Global Puerarin Production by Type (2027–2032)
5.1.3 Global Puerarin Production Market Share by Type (2021–2032)
5.2 Global Puerarin Production Value by Type (2021–2032)
5.2.1 Global Puerarin Production Value by Type (2021–2026)
5.2.2 Global Puerarin Production Value by Type (2027–2032)
5.2.3 Global Puerarin Production Value Market Share by Type (2021–2032)
5.3 Global Puerarin Price by Type (2021–2032)
6 Segment by Application
6.1 Global Puerarin Production by Application (2021–2032)
6.1.1 Global Puerarin Production by Application (2021–2026)
6.1.2 Global Puerarin Production by Application (2027–2032)
6.1.3 Global Puerarin Production Market Share by Application (2021–2032)
6.2 Global Puerarin Production Value by Application (2021–2032)
6.2.1 Global Puerarin Production Value by Application (2021–2026)
6.2.2 Global Puerarin Production Value by Application (2027–2032)
6.2.3 Global Puerarin Production Value Market Share by Application (2021–2032)
6.3 Global Puerarin Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Ankang Health Element
7.1.1 Ankang Health Element Puerarin Company Information
7.1.2 Ankang Health Element Puerarin Product Portfolio
7.1.3 Ankang Health Element Puerarin Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Ankang Health Element Main Business and Markets Served
7.1.5 Ankang Health Element Recent Developments/Updates
7.2 Jiangsu Tiansheng
7.2.1 Jiangsu Tiansheng Puerarin Company Information
7.2.2 Jiangsu Tiansheng Puerarin Product Portfolio
7.2.3 Jiangsu Tiansheng Puerarin Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Jiangsu Tiansheng Main Business and Markets Served
7.2.5 Jiangsu Tiansheng Recent Developments/Updates
7.3 Xi'an Plamed
7.3.1 Xi'an Plamed Puerarin Company Information
7.3.2 Xi'an Plamed Puerarin Product Portfolio
7.3.3 Xi'an Plamed Puerarin Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Xi'an Plamed Main Business and Markets Served
7.3.5 Xi'an Plamed Recent Developments/Updates
7.4 Xi'an Sobeo
7.4.1 Xi'an Sobeo Puerarin Company Information
7.4.2 Xi'an Sobeo Puerarin Product Portfolio
7.4.3 Xi'an Sobeo Puerarin Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Xi'an Sobeo Main Business and Markets Served
7.4.5 Xi'an Sobeo Recent Developments/Updates
7.5 Ankang Health Element
7.5.1 Ankang Health Element Puerarin Company Information
7.5.2 Ankang Health Element Puerarin Product Portfolio
7.5.3 Ankang Health Element Puerarin Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Ankang Health Element Main Business and Markets Served
7.5.5 Ankang Health Element Recent Developments/Updates
7.6 Shanxi Zhongyi Herb
7.6.1 Shanxi Zhongyi Herb Puerarin Company Information
7.6.2 Shanxi Zhongyi Herb Puerarin Product Portfolio
7.6.3 Shanxi Zhongyi Herb Puerarin Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Shanxi Zhongyi Herb Main Business and Markets Served
7.6.5 Shanxi Zhongyi Herb Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Puerarin Industry Chain Analysis
8.2 Puerarin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Puerarin Production Modes and Processes
8.4 Puerarin Sales and Marketing
8.4.1 Puerarin Sales Channels
8.4.2 Puerarin Distributors
8.5 Puerarin Customer Analysis
9 Puerarin Market Dynamics
9.1 Puerarin Industry Trends
9.2 Puerarin Market Drivers
9.3 Puerarin Market Challenges
9.4 Puerarin Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Puerarin was estimated to be worth US$ 119 million in 2025 and is projected to reach US$ 186 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
The global Puerarin market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 176 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
The global Puerarin market is projected to grow from US$ 112 million in 2024 to US$ 176 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 137
USD 4900.00
(Single User License)
The global market for Puerarin was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 176 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-01-16
Pages: 90
USD 2900.00
(Single User License)
The global market for Puerarin was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 176 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 94
USD 3950.00
(Single User License)
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published Date: 2024-04-12
Pages: 89
USD 4900.00
(Single User License)
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published Date: 2024-01-10
Pages: 94
USD 3950.00
(Single User License)
The global market for Puerarin was estimated to be worth US$ 119 million in 2025 and is projected to reach US$ 186 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
The global Puerarin market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 176 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
The global Puerarin market is projected to grow from US$ 112 million in 2024 to US$ 176 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 137
The global market for Puerarin was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 176 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-01-16
Pages: 90
The global market for Puerarin was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 176 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 94
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published: 2024-04-12
Pages: 89
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published: 2024-01-17
Pages: 90
Puerarin is a natural isoflavone compound derived from the root of the Pueraria lobata plant, commonly known as Kudzu. It is one of the main bioactive components found in Puerariae radix and has been used in traditional Chinese medicine for its potential health benefits. Puerarin possesses various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, neuroprotective, and anti-cancer effects. It has been studied for its potential application in treating cardiovascular diseases, neurodegenerative disorders, metabolic disorders, and even alcohol-related liver diseases, making it a subject of interest in pharmaceutical and medicinal research.
Published: 2024-01-10
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now